The interview discusses the challenges and complexities of Japan's regulatory framework, particularly in the medical and dental sectors. Despite recent improvements like the sakigake system and the PMD Act, regulatory processes remain slow, hindering innovation and market entry. Sangi, a hydroxyapatite provider, exemplifies these challenges,...